# Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose

> **NCT02729064** · PHASE1 · UNKNOWN · sponsor: **Hiroaki Sato, MD., PhD.** · enrollment: 141 (estimated)

## Conditions studied

- Ischemic Heart Disease
- Aortic Aneurysm

## Interventions

- **DRUG:** Humulin R
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02729064
- **Lead sponsor:** Hiroaki Sato, MD., PhD.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 141 (ESTIMATED)
- **Last updated:** 2021-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02729064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02729064, "Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02729064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*